Aurinia Pharmaceuticals Inc. Annual Cost of Revenue in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Aurinia Pharmaceuticals Inc. quarterly/annual Cost of Revenue history and growth rate from 2019 to 2023.
  • Aurinia Pharmaceuticals Inc. Cost of Revenue for the quarter ending September 30, 2024 was $6.04M, a 10.8% decline year-over-year.
  • Aurinia Pharmaceuticals Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $28.1M, a 178% increase year-over-year.
  • Aurinia Pharmaceuticals Inc. annual Cost of Revenue for 2023 was $14.1M, a 150% increase from 2022.
  • Aurinia Pharmaceuticals Inc. annual Cost of Revenue for 2022 was $5.66M, a 419% increase from 2021.
  • Aurinia Pharmaceuticals Inc. annual Cost of Revenue for 2021 was $1.09M.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $14.1M +$8.48M +150% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 $5.66M +$4.57M +419% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 $1.09M +$1.09M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $0 $0 Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $0 Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.